Correlation between clinicopathological characteristics and the clinical prognosis of patients with gastroenteropancreatic neuroendocrine tumors

被引:1
|
作者
Fan, Dongwei [1 ]
Li, Xuanhe [2 ]
Yu, Yousheng [1 ]
Wang, Xingliang [1 ]
Fang, Jun [1 ]
Huang, Cheng [1 ,3 ]
机构
[1] West Anhui Hlth Vocat Coll, Affiliated Hosp, Dept Gen Surg, Luan 237000, Anhui, Peoples R China
[2] Bengbu Med Coll, Affiliated Hosp 1, Dept Surg Oncol, Bengbu 233000, Anhui, Peoples R China
[3] West Anhui Hlth Vocat Coll, Affiliated Hosp, Dept Gen Surg, 73 Mozitan Rd, Luan 237000, Anhui, Peoples R China
关键词
gastroenteropancreatic neuroendocrine tumor; clinical and pathological characteristics; prognostic factors; SERUM CHROMOGRANIN-A; CONSENSUS GUIDELINES; DIAGNOSIS; MANAGEMENT; CLASSIFICATION; RATIONALE; NEOPLASMS; FEATURES; TRACT;
D O I
10.3892/mco.2023.2681
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are one of the most common types of NETs, accounting for 65-75% of all NETs. However, epidemiological characteristics of patients with GEP-NETs in China are still lacking. The present retrospective study aimed to investigate the local epidemiology of GEP-NETs and assess the prognostic factors in China. The data of 267 patients with GEP-NETs who were admitted to the First Affiliated Hospital of Bengbu Medical College (Bengbu, China) and the Affiliated Hospital of West Anhui Health Vocational College (Lu'an, China) were retrospectively reviewed. The clinical and pathological characteristics of the patients, as well as follow-up information, were collected, and the 5-year survival rate was calculated. Kaplan-Meier curves and log-rank analysis were used to analyze the prognostic factors. The stomach (100/267; 37.5%) was the most common site of GEP-NETs and the liver (25/39; 64.1%) was the most common metastatic site. A total of 166 (62.2%) and 219 (82.0%) patients had positive results for chromogranin A (CgA) and synaptophysin (Syn), respectively. The percentage of patients with tumor grade G1, G2 and G3 was 33.3, 21.0 and 45.7%, respectively. The 5-year overall survival rate was 79.7%, and the age, tumor site, distant metastasis and tumor grading upon diagnosis were all prognostic factors. In conclusion, the present case series investigated the epidemiology and prognostic factors of GEP-NETs in China. CgA and Syn could be used as diagnostic markers for NETs and the stomach was the most common primary tumor site. Lymph node metastasis, tumor site, distant metastasis and tumor grading were important prognostic factors.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors
    Strosberg, Jonathan
    Nasir, Aejaz
    Coppola, Domenico
    Wick, Mark
    Kvols, Larry
    HUMAN PATHOLOGY, 2009, 40 (09) : 1262 - 1268
  • [2] Clinicopathological Features and Prognosis of Gastroenteropancreatic Neuroendocrine Tumors: Analysis from a Single-institution
    Zeng, Yu-Jie
    Liu, Lu
    Wu, Heng
    Lai, Wei
    Cao, Jie-Zhi
    Xu, He-Yang
    Wang, Jie
    Chu, Zhong-Hua
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (10) : 5775 - 5781
  • [3] Gastroenteropancreatic neuroendocrine tumors: Clinical characteristics, diagnosis and prognosis at Hospital Universitario Clinico San Carlos (Madrid)
    Paz de Miguel Novoa, Maria
    Capel, Francisco Fernandez
    Redondo Sedano, Jesus Vicente
    Sellers Carrera, Margarita
    Aranda Jimenez, Veronica
    Ortiz Pereira, Paloma
    Sastre Valera, Javier
    Ortega Medina, Luis
    Diaz Perez, Jose Angel
    ENDOCRINOLOGIA Y NUTRICION, 2014, 61 (05): : 234 - 241
  • [4] Clinicopathological Characteristics of Gastroenteropancreatic Neuroendocrine Tumors 10 Years of Experience From a Single Center
    Senturk, Mustafa
    Acar, Berkan
    Yildirim, Mehmet Aykut
    Cakir, Murat
    Kucukkartallar, Tevfik
    Vatansev, Celalettin
    PANCREAS, 2022, 51 (02) : 159 - 163
  • [5] CD44v6 expression in gastroenteropancreatic neuroendocrine neoplasms: Clinicopathological correlation and prognosis
    Nibhondhratana, Pisuth
    Watcharadetwittaya, Sasithorn
    Sa-ngiamwibool, Prakasit
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 240
  • [6] Establishment and validation of a clinicopathological prognosis model of gastroenteropancreatic neuroendocrine carcinomas
    Chen, Jing
    Liu, Yibing
    Xu, Ke
    Ren, Fei
    Li, Bowen
    Sun, Hong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Prognostic factors of the clinical outcome for patients with gastroenteropancreatic neuroendocrine tumors
    Huang, Pao-Yuan
    Hu, Ming-Luen
    Liang, Chih-Ming
    Tai, Wei-Chen
    Wu, Keng-Liang
    Chiu, Yi-Chun
    Chuah, Seng-Kee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 111 - 111
  • [8] Gastroenteropancreatic Neuroendocrine Tumors: Single-Institution Clinicopathological Study
    Vaslamatzis, M.
    Papaxoinis, G.
    Tsiga, A.
    Mantzaris, G.
    Exarchos, D.
    Alfaras, P.
    Delaki, C.
    Alevizopoulos, N.
    Patila, E.
    Zoublios, C.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 64 - 64
  • [9] Neuroendocrine tumors of the gastroenteropancreatic tract: Patient characteristics, survival and clinical outcome
    Berndt, U
    Pape, UF
    Bohmig, M
    Tiling, N
    Plockinger, U
    Wiedennamn, B
    GASTROENTEROLOGY, 2004, 126 (04) : A392 - A392
  • [10] Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract
    Rindi, G
    Capella, C
    Solcia, E
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE, 2000, 44 (01): : 13 - 21